Express Scripts Holding Co (NASDAQ:ESRX) – Equities researchers at William Blair raised their FY2018 EPS estimates for shares of Express Scripts in a research report issued on Wednesday, October 31st. William Blair analyst J. Kreger now anticipates that the company will post earnings per share of $9.08 for the year, up from their prior forecast of $9.07. William Blair currently has a “Market Perform” rating on the stock. William Blair also issued estimates for Express Scripts’ Q3 2019 earnings at $2.51 EPS, FY2019 earnings at $9.74 EPS, FY2020 earnings at $8.05 EPS and FY2021 earnings at $6.96 EPS.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The business had revenue of $25.56 billion during the quarter, compared to the consensus estimate of $25.11 billion. During the same quarter in the previous year, the business earned $2.51 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis.
Shares of NASDAQ ESRX opened at $96.74 on Monday. Express Scripts has a twelve month low of $59.17 and a twelve month high of $98.98. The company has a market capitalization of $54.55 billion, a PE ratio of 13.63, a price-to-earnings-growth ratio of 1.22 and a beta of 0.89. The company has a current ratio of 0.77, a quick ratio of 0.59 and a debt-to-equity ratio of 0.63.
In related news, insider Christine Houston sold 12,898 shares of Express Scripts stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the sale, the insider now owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.79% of the company’s stock.
Several large investors have recently bought and sold shares of ESRX. Principal Financial Group Inc. raised its holdings in shares of Express Scripts by 17.4% in the 1st quarter. Principal Financial Group Inc. now owns 969,252 shares of the company’s stock worth $66,956,000 after purchasing an additional 143,479 shares during the period. IFM Investors Pty Ltd raised its holdings in shares of Express Scripts by 44.8% in the 2nd quarter. IFM Investors Pty Ltd now owns 25,578 shares of the company’s stock worth $1,975,000 after purchasing an additional 7,916 shares during the period. Moon Capital Management LLC bought a new stake in shares of Express Scripts in the 2nd quarter worth approximately $3,653,000. Fisher Asset Management LLC raised its holdings in shares of Express Scripts by 3.8% in the 2nd quarter. Fisher Asset Management LLC now owns 416,456 shares of the company’s stock worth $32,155,000 after purchasing an additional 15,366 shares during the period. Finally, Hudson Valley Investment Advisors Inc. ADV bought a new stake in shares of Express Scripts in the 2nd quarter worth approximately $1,540,000. 84.74% of the stock is currently owned by institutional investors.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More: Stock Selection – What is cash flow?
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.